Overview: Limitations of Current Treatment of Depression Maurizio Fava, MD

Assessing and Managing Metabolic Risk in Bipolar Disorder and Schizophrenia Dost Ongur, MD, PhD

Long-Acting Injectable (LAI) Antipsychotics in Bipolar Disorder and Schizophrenia Oliver Freudenreich, MD, FAPM

Assessment and Treatment of Affective Symptoms in Schizophrenia Oliver Freudenreich, MD, FAPM

Optimal Treatment of Psychosis in Bipolar Disorder Sharmin Ghaznavi, MD, PhD

Early Detection and Intervention in Bipolar Disorder and Schizophrenia Andrew A. Nierenberg, MD

Anxiety and Depression: Pharmacological Approaches Cristina Cusin, MD

Anxiety in the Setting of Depression: Risk, Comorbidity, and Residual Symptoms Naomi Simon, MD, MSc

Cognitive Dysfunction in Depressed Patients Andrew Nierenberg, MD

Pharmacotherapeutic Approaches to Fatigue and Depression David Mischoulon, MD, PhD